Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest
The German Psoriasis Registry PsoBest was conducted in 2008 in order to investigate the long-term outcomes and safety of systemic treatments for moderate-to-severe psoriasis. Safety analysis of antipsoriatic drugs with special focus on serious adverse events (SAE) for infections, malignancies and ma...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer Berlin Heidelberg
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643107/ |